118 related articles for article (PubMed ID: 4032751)
1. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
2. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
3. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of serum squamous cell carcinoma-related antigen levels in penile cancer].
Takahashi Y; Horie M; Isogai K; Takeuchi T; Shinoda I; Kuriyama M; Ban Y
Hinyokika Kiyo; 1987 Mar; 33(3):396-9. PubMed ID: 3618407
[TBL] [Abstract][Full Text] [Related]
6. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
8. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
10. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
11. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].
Nagai M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):612-6. PubMed ID: 6715941
[TBL] [Abstract][Full Text] [Related]
13. [Basic evaluation of measurement of the serum level of squamous cell carcinoma-related antigen (SCC) and its value following irradiation of cancer of the uterine cervix].
Obata Y; Tadokoro M; Kazato S; Nishi H; Ito M; Shibata H; Mizuno K; Kawamura N; Yamaguchi T; Yoshizumi T
Gan No Rinsho; 1987 Jan; 33(1):60-4. PubMed ID: 3820601
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
16. [The measurement of SCC antigen in squamous cell carcinoma of the lung].
Masuoka T; Matueda Y; Ookawa H; Watanabe K; Mimoto S
Gan No Rinsho; 1985 Jul; 31(8):914-8. PubMed ID: 4032769
[TBL] [Abstract][Full Text] [Related]
17. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
18. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
